Literature DB >> 12050515

Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population.

Lars Henningsohn1, Kenneth Steven, Else Brohm Kallestrup, Gunnar Steineck.   

Abstract

PURPOSE: We compared subjective quality of life, well-being, urinary tract symptoms and distress in patients after radical cystectomy and orthotopic urinary reconstruction with those in a matched control population.
MATERIALS AND METHODS: Included in this study were 101 consecutive recurrence-free patients who underwent radical cystectomy and orthotopic bladder substitution with an ileal urethral Kock neobladder at Herlev Hospital with a minimum followup of 1 year. A frequency matched control group comprising 147 individuals was selected from the same geographical region. Information was collected by an anonymous postal questionnaire and analyzed externally in Sweden.
RESULTS: The prevalence of low or moderate psychological well-being (32% versus 36%) and subjective quality of life (30% versus 38%), and high or moderate anxiety (23% versus 18%) and depression (26% versus 37%) was similar in patients with an orthotopic neobladder and population controls. Patients with a neobladder felt as attractive as the control population. Of the operated men 94% had erectile dysfunction compared with 48% of controls. Daytime and nighttime urinary frequency was similar in patients and controls (3% and 3%, and 15% and 13%, respectively), while the prevalence of urinary leakage at least once monthly was higher in patients (18% versus 5%). Intermittent self-catheterization was performed by 26% of patients with a neobladder. Urinary tract infection (14% versus 6%) was more common and the prevalence of distressful bowel symptoms (14% versus 9%) was slightly more common in patients than in controls.
CONCLUSIONS: Well-being and subjective quality of life in patients after radical cystectomy and orthotopic bladder substitution were similar to those in a matched control population.

Entities:  

Mesh:

Year:  2002        PMID: 12050515     DOI: 10.1016/s0022-5347(05)64854-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

1.  Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Authors:  Raymond H Mak; Daniel Hunt; William U Shipley; Jason A Efstathiou; William J Tester; Michael P Hagan; Donald S Kaufman; Niall M Heney; Anthony L Zietman
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

2.  Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.

Authors:  Kevin R Kozak; Maryam Hamidi; Matthew Manning; John S Moody
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-06       Impact factor: 7.038

Review 3.  [Complementary and alternative medicine in urologic oncology].

Authors:  T Otto; J Suhr; H Rübben
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

Review 4.  [Quality of life after radical urologic pelvic surgery and impact of inpatient rehabilitation].

Authors:  O Dombo; U Otto
Journal:  Urologe A       Date:  2005-01       Impact factor: 0.639

5.  Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort.

Authors:  Florian Roghmann; Andreas Becker; Quoc-Dien Trinh; Orchidee Djahangirian; Orchidee Djahagirian; Zhe Tian; Malek Meskawi; Shahrokh F Shariat; Markus Graefen; Pierre Karakiewicz; Joachim Noldus; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

Review 6.  Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Arnulf Stenzl; Markus Kuczyk
Journal:  World J Urol       Date:  2011-02-05       Impact factor: 4.226

7.  [Patients' acceptance of urinary diversion. The pouch of Sisyphus].

Authors:  F-C von Rundstedt; S Roth; C R J Woodhouse; W Månsson; E W Gerharz
Journal:  Urologe A       Date:  2012-04       Impact factor: 0.639

8.  Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China.

Authors:  Hai Tao Niu; Haitao Niu; Shi Xiu Shao; Shixiu Shao; Zong Liang Zhang; Zongliang Zhang; Shuai Wu; Bo Cheng; De Quan Pang; Dequan Pang; Ya Jun E; Yajun E; Sheng Guo Dong; Shengguo Dong; Guang Sun; Ji Wu Chang; Jiwu Chang
Journal:  Int Urol Nephrol       Date:  2008-09-23       Impact factor: 2.370

9.  Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Donald S Kaufman; Michael P Hagan; Niall M Heney; Howard M Sandler
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

Review 10.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.